Isolated cardiac troponin rise does not modify the prognosis in elderly patients with hip fracture

Hélène Vallet1, Alice Breining, Yannick Le Manach

  • 1Sorbonne Universités UPMC Univ Paris 06, DHU FAST UMRS INSERM 1166, IHU ICAN UMRS INSERM 1158 Department of Geriatry Department of Anesthesiology and Critical Care Department of Emergency Medicine and Surgery Department of Orthopedic Surgery and Trauma Groupe Hospitalier (GH) Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France Departments of Anesthesia & Clinical Epidemiology and Biostatistics, Michael DeGroote School of Medicine, Population Health Research Institute, Perioperative Medicine and Surgical Research Unit, Faculty of Health Sciences, McMaster University, Hamilton, Canada Department of Rehabilitation, GH Charles Foix, APHP, Ivry sur Seine Centre National de la Recherche Scientifique (CNRS), Paris, France.

Medicine
|February 17, 2017
PubMed

Insights

Isolated troponin rise (ITR) in elderly hip fracture patients did not significantly increase 6-month mortality or rehospitalization. Acute coronary syndrome (ACS) was associated with worse outcomes, highlighting the need for differentiated risk assessment.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Orthopedic Surgery

Background:

  • Perioperative myocardial infarction is a serious complication after noncardiac surgery.
  • Even an isolated troponin rise (ITR) can be linked to significant mortality.
  • Assessing the prognostic value of ITR in elderly hip fracture patients is crucial.

Purpose of the Study:

  • To evaluate the prognostic significance of isolated troponin rise (ITR) in elderly patients undergoing hip fracture surgery.
  • To compare outcomes between patients with ITR, acute coronary syndrome (ACS), and a control group.

Main Methods:

  • A cohort study included 312 elderly patients (mean age 85) undergoing hip fracture surgery.
  • Patients were categorized into Control, ITR, and ACS groups based on cardiac troponin I levels.
  • Primary endpoint was a composite of 6-month mortality and/or re-hospitalization; secondary endpoints included mortality and functional outcomes.

Main Results:

  • No significant difference in postoperative complications between ITR and Control groups.
  • ACS group showed higher rates of atrial fibrillation, heart failure, hemorrhage, and ICU admission.
  • Six-month mortality/re-hospitalization was not significantly increased in the ITR group (28%) compared to Control (26%).
  • ACS group had significantly increased 6-month mortality/re-hospitalization (44%) versus Control (26%).
  • ITR was not linked to increased institutionalization or impaired walking ability at 6 months.

Conclusions:

  • In elderly patients with hip fractures, isolated troponin rise (ITR) is not associated with increased 6-month mortality or re-hospitalization.
  • Acute coronary syndrome (ACS) in this population is linked to significantly worse outcomes.
  • Risk stratification should differentiate between ITR and ACS following hip fracture surgery.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
355
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
278
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
360
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.0K